- Sensei Biotherapeutics Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Sensei Biotherapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Sensei Biotherapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Sensei Biotherapeutics Inc at Citi Virtual Oncology Leadership Summit TranscriptFeb 23, 2023
- Sensei Biotherapeutics Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Sensei Biotherapeutics Inc at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Sensei Biotherapeutics Inc Virtual VISTA Science Symposium TranscriptNov 16, 2021
- Sensei Biotherapeutics Inc to Discuss Prioritization of SNS-401-NG and SNS-VISTA Call TranscriptJun 28, 2021
Sensei Biotherapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Hello, everyone. Thank you for your time and attention today. I'm very happy to present to you Sensei Bio's conditionally active antibodies for immuno-oncology. But first, I just want to thank Oppenheimer for inviting us to the conference and for their continued support. Oppenheimer played an important role in Sensei Bio's IPO two years ago.
As you can see from our cover slide, we are an immuno-oncology company developing conditionally active antibodies. And we're going to talk about what conditionally active antibodies are throughout the presentation.
But before I get started, I will be making forward-looking statements here today, and this is our disclaimer.
Now, at Sensei Bio, we're particularly focused on one of the key challenges in immuno-oncology, and that is that many antibodies fail because of off-tumor binding. Systemically delivered immuno-oncology drugs are developed in a fairly canonical way and are developed to bind to targets both in the tumor and in the periphery. And this creates, in our view,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)